?Afloqualone Intermediate (CAS 1125812-58-9)?
Google Keywords: Afloqualone Intermediate, CAS 1125812-58-9, Muscle Relaxant Synthesis, Pharmaceutical Intermediates, GMP API Production

?? ?Product Overview?

?Afloqualone Intermediate? (CAS 1125812-58-9) is a high-purity chemical building block essential for synthesizing ?Afloqualone?, a potent muscle relaxant used to treat spasticity and neurological disorders. Designed for API manufacturing, this intermediate ensures efficient and scalable production with strict quality control.

• ?Primary Function?: Enables precise synthesis of Afloqualone with controlled impurity levels.

• ?Applications?: Muscle relaxant APIs, neurological drug development, and generic formulations.

? ?Key Advantages?

?? ?Ultra-High Purity? | ≥99% (HPLC/GC verified) | Low heavy metal content (<10 ppm).
?? ?Stability? | Long shelf life (24 months) under recommended storage conditions.
?? ?GMP Readiness? | Compliant with ICH Q7 and ISO 9001 standards for pharmaceutical intermediates.

?? ?Applications?

1. ?Muscle Relaxant Production?: Core component in Afloqualone API synthesis for spasticity management.

2. ?Neurological Research?: Supports preclinical studies targeting CNS disorders.

3. ?Generic Drug Manufacturing?: Critical for post-patent API scale-up.

?? ?Quality Assurance?

• ?Testing Methods?: HPLC, GC, NMR, and ICP-MS for purity and trace element analysis.

• ?Standards?: Meets USP/EP specifications for pharmaceutical intermediates.

?? ?Market Trends?

The global muscle relaxant market is projected to grow at ?6.3% CAGR (2024-2030)?, fueled by rising demand for non-opioid therapies and neurological disorder treatments. Afloqualone intermediates are vital in addressing unmet needs in spasticity and chronic pain management.

Empower your API production with Afloqualone Intermediate – purity, compliance, and reliability for advanced therapeutics.